V

Vivo Bio Tech Ltd
BSE:511509

Watchlist Manager
Vivo Bio Tech Ltd
BSE:511509
Watchlist
Price: 27.15 INR 2.76% Market Closed
Market Cap: ₹600m

Net Margin

8.2%
Current
Declining
by 0.7%
vs 3-y average of 8.9%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
8.2%
=
Net Income
₹40.9m
/
Revenue
₹501.2m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
8.2%
=
Net Income
₹40.9m
/
Revenue
₹501.2m

Peer Comparison

Country Company Market Cap Net
Margin
IN
Vivo Bio Tech Ltd
BSE:511509
583.9m INR
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Eli Lilly and Co
NYSE:LLY
972.2B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.5B USD
Loading...
US
Abbvie Inc
NYSE:ABBV
393.1B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.1B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.4B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
272.1B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...

Market Distribution

In line with most companies in India
Percentile
60th
Based on 5 531 companies
60th percentile
8.2%
Low
-305 007.7% — 2.1%
Typical Range
2.1% — 11.6%
High
11.6% — 1 221 633.3%
Distribution Statistics
India
Min -305 007.7%
30th Percentile 2.1%
Median 5.8%
70th Percentile 11.6%
Max 1 221 633.3%

Vivo Bio Tech Ltd
Glance View

Market Cap
600m INR
Industry
N/A

Vivo Bio Tech Ltd. engages in the provision of drug development and discovery services. The company is headquartered in Hyderabad, Telangana. The firm provides services of in-vitro, in-vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies. The firm's services are offered to pharma, biotech and Agri companies, which include molecular biology services, the fermentation process of E.Coli harboring the plasmid containing the gene of interest, protein purification, bioassay, Physico-chemical and biochemical/immunological characterization of various proteins. The firm's In-vivo services provide preclinical testing services in rodents/non-rodents, and canines. The firm's subsidiaries include Vivobio Labs Private Ltd, Vivobio Discovery services Private Ltd, Surlogic Life Consultancy Private Ltd and Vivobio Consulting Services Private Ltd.

VIVOBIOT Intrinsic Value
39.37 INR
Undervaluation 31%
Intrinsic Value
Price
V
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
8.2%
=
Net Income
₹40.9m
/
Revenue
₹501.2m
What is Vivo Bio Tech Ltd's current Net Margin?

The current Net Margin for Vivo Bio Tech Ltd is 8.2%, which is below its 3-year median of 8.9%.

How has Net Margin changed over time?

Over the last 3 years, Vivo Bio Tech Ltd’s Net Margin has increased from 2.2% to 8.2%. During this period, it reached a low of -0.2% on Dec 31, 2022 and a high of 17.2% on Jun 30, 2025.

Back to Top